Alison Taunton-Rigby Joins American Healthways Board Of Directors.NASHVILLE, Tenn. -- American Healthways Inc., (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AMHC AMHC Association of Mental Health Clergy AMHC Aviation Structural Mechanic Hydraulics Chief ) today announced the appointment of Alison Taunton-Rigby Ph.D., OBE to the Company's Board of Directors. Dr. Taunton-Rigby is the founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Ribonovix, Inc., an early-stage biotechnology company developing novel antibiotics using a functional genomics technology, and currently serves on the boards of directors of Abt Associates, Idera Pharmaceuticals and the RiverSource Funds (formerly American Express). She is also on the boards of the Massachusetts Biotechnology Council and The Children's Hospital, Boston. "Dr. Taunton-Rigby's experience and reputation as an entrepreneur and as a leader in the biotechnology industry further strengthens our Board and the Company's focus on innovation, new markets and improving health outcomes," Chairman Thomas G. Cigarran said. "Dr. Taunton-Rigby is an asset to the Board, and we appreciate her willingness to serve." Prior to founding her own company, Dr. Taunton-Rigby was president, CEO and director of several private and publicly traded companies, including CMT CMT Certified Medical Transcriptionist. CMT abbr. Certified Medical Transcriptionist CMT California mastitis test. , Inc., Aquila Biopharmaceuticals, Inc., Cambridge Biotech Corporation and Mitotix, Incorporated. Her previous work also includes various leadership positions with Genzyme Corporation, Arthur D. Little Arthur D. Little, Inc. is the world's first management consulting firm. Founded in 1886 by Arthur Dehon Little, an MIT chemist who discovered acetate, and co-worker Roger Griffin, in Cambridge, Massachusetts, Arthur D. Little pioneered the concept of contracted technology research. , Inc., Vivotech, Inc., Biogen, Inc. and Collaborative Research, Inc. (Oscient Pharmaceuticals). In 2002, Dr. Taunton-Rigby was honored by Her Majesty Queen Elizabeth II as an Officer of the Order of the British Empire (OBE) for her leadership in the research, development and promotion of biotechnology. She also received the Presidential Medal from Worcester Polytechnic Institute Worcester Polytechnic Institute - (WPI) A well-regarded, small engineering college. Address: Worcester, MA, USA. in 2001. Dr. Taunton-Rigby is active at the state and national levels as a representative of the biotechnology industry and has testified before Congress on drug pricing issues, drug regulation, bioethics bioethics, in philosophy, a branch of ethics concerned with issues surrounding health care and the biological sciences. These issues include the morality of abortion, euthanasia, in vitro fertilization, and organ transplants (see transplantation, medical). and human cloning. She earned her bachelor's and doctoral degrees in chemistry from the University of Bristol, England, and completed the Advanced Management Program at the Harvard School of Business. "I am honored to join the Board of a company that is focused on making a difference in people's lives through the application of groundbreaking health-care solutions," Dr. Taunton-Rigby said. "I look forward to working with American Healthways in pursuit of better health care, improved quality of life and reduced costs for those served by our health-care system." Dr. Taunton-Rigby joins Company directors: John W. Ballantine, former executive vice president and chief risk management officer of First Chicago NBD NBD Next Business Day NBD National Bank of Dubai (United Arab Emirates) NBD No Big Deal NBD Network Block Device (Linux) NBD Nucleotide Binding Domain NBD New Business Development , and current chairman of the financial services advisory group for Glencoe Capital; Jay Crispin Bisgard, M.D., former director of health services health services Managed care The benefits covered under a health contract at Delta Air Lines; Tom Cigarran, chairman and former chief executive officer of American Healthways; Frank A. Ehmann, former president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of American Hospital Supply Corporation; Mary Jane England, M.D., President, Regis College; Henry D. Herr, former executive vice president and chief financial officer of American Healthways; Ben R. Leedle, Jr., president and chief executive officer of American Healthways; Dr. C. Warren Neel, executive director of the University of Tennessee The University of Tennessee (UT), sometimes called the University of Tennessee at Knoxville (UT Knoxville or UTK), is the flagship institution of the statewide land-grant University of Tennessee public university system in the American state of Tennessee. Corporate Governance Center; and William C. O'Neil, Jr., former chairman, president and chief executive officer of ClinTrials, Inc. About American Healthways American Healthways is the nation's leading and largest provider of disease management, care enhancement and high-risk health management services proven to improve the quality of health care and lower costs. As of Aug. 31, 2005, the company had nearly 1.9 million lives under management worldwide. For more information visit www.americanhealthways.com. Safe Harbor Provisions This press release contains forward-looking statements that are based upon current expectations and involve a number of risks and uncertainties. In order for American Healthways to utilize the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, investors are hereby cautioned that these statements may be affected by the important factors, among others, included in the discussion in Part I, Item 1, and Part II, Item 7, of American Healthways' Annual Report on Form 10-K for the fiscal year ended August 31, 2005. Consequently, actual operations and results may differ materially from those expressed in these forward-looking statements. American Healthways undertakes no obligation to update or revise any such forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion